Skip to main content
Novartis
language-selector-globe United States | en
Choose Location
  • Americas
  • Asia Pacific
  • Europe
  • International
  • Middle East & Africa
Argentina | Español
Brazil | Português
Canada | English
Canada | Français
Central America | Español
Colombia | Español
Mexico | Español
United States | English
Australia | English
Bangladesh | English
Hong Kong S.A.R. | 繁體中文
India | English
Indonesia | English
Japan | 日本語
Korea | 한국어
Mainland China | 中文
Malaysia | English
Pakistan | English
Philippines | English
Singapore | English
Taiwan | 繁體中文
Thailand | ภาษาไทย
Austria | Deutsch
Belgium | Français
Belgium | Nederlands
Bulgaria | Български
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hungary | Magyar
Ireland | English
Italy | Italiano
Latvia | Latvian
Lithuania | Lithuanian
Netherlands | Nederlands
Norway | Norsk
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Serbia | Srpski
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Türkiye | Türkçe
United Kingdom | English
Global | English
Novartis Foundation | English
Egypt | English
Israel | עברית
Saudi Arabia | العربية
South Africa | English
language-selector-globe us
Choose Location
Americas Asia Pacific Europe International Middle East & Africa
Argentina | Español
Australia | English
Austria | Deutsch
Bangladesh | English
Belgium | Français
Belgium | Nederlands
Brazil | Português
Bulgaria | Български
Canada | English
Canada | Français
Central America | Español
Colombia | Español
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Egypt | English
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hong Kong S.A.R. | 繁體中文
Hungary | Magyar
India | English
Indonesia | English
Ireland | English
Israel | עברית
Italy | Italiano
Japan | 日本語
Korea | 한국어
Latvia | Latvian
Lithuania | Lithuanian
Mainland China | 中文
Malaysia | English
Mexico | Español
Netherlands | Nederlands
Norway | Norsk
Global | English
Novartis Foundation | English
Pakistan | English
Philippines | English
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Saudi Arabia | العربية
Serbia | Srpski
Singapore | English
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
South Africa | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Taiwan | 繁體中文
Thailand | ภาษาไทย
Türkiye | Türkçe
United Kingdom | English
United States | English
    • About 
      • Novartis in the US 
        • Diversity equity & inclusion  
        • Pay transparency-EPIC 
        • Our code of ethics 
      • Diversity, equity & inclusion  
        • Novartis US EEO / D&I report 2021 
        • Supplier diversity 
      • People and culture 
      • Products 
      • US Country Coordinating Committee 
      • External funding 
      • Contact us 
      Team meeting About
    • Patients and caregivers 
      • Novartis commitment to patients and caregivers 
      • Patient assistance 
      • Diseases 
        • Chronic spontaneous urticaria (CSU) 
        • Hidradenitis suppurativa (HS) 
        • Prostate Cancer (PC) 
        • Paroxysmal Nocturnal Hemoglobinuria (PNH) 
      • Participating in clinical trials 
      • Patient perspectives 
      • Adverse event reporting 
      • The STEP program 
        • Sickle cell disease (SCD) 
        • Program overview 
        • Multiple sclerosis (MS) 
        • Cancer 
        • Application for funding to help address health disparities 
        • Health disparities 
      • Patient resources 
      Patient smiling at doctor image Patients and caregivers
    • Healthcare professionals 
      • Novartis pipeline 
      • Novartis clinical trials 
      • Adverse event reporting 
      • HCP resources 
      • Personalized and Precision Medicine 
      • Health Information Technology Resources 
      Two doctors examining X-ray Healthcare professionals
    • ESG 
      • Ethical behavior 
        • Code of ethics 
        • SpeakUp 
        • PhRMA Code on interactions with healthcare professionals 
        • Business principles 
      • Ethics, risk and compliance 
        • Compliance program 
        • State laws 
        • Corporate integrity agreement 
        • Payments to HCPs & HCOs 
        • Drug Supply Chain Security Act Information 
      • Corporate responsibility 
        • Population health 
        • Novartis in society US reports 
        • Novartis US Foundation 
        • Environmental sustainability 
        • People and communities 
      • Beacon of hope 
        • Beacon of hope: Measurable solutions for health equity 
        • Paving the way for a brighter, more equitable future 
      Novartis East Hanover Campus Landscaping ESG
    • News 
      • News archive 
      • Statements 
      • Stories 
      • Contacts 
      Co-workers having a meeting News
    • Careers 
      • Career search 
      • Meet the teams 
      • Early career 
      • Personal growth 
      • How we work 
      • Employee benefits 
      • Diversity, equity & inclusion 
      • Awards & recognition 
      Meeting in Atrium Careers
    Grandmother, mother and daughter smiling and laughing on a beach Home
  1. Home
  2. Careers
  3. Career Search
  • Sort by Sort ascending
  • Job Title
  • Site
  • Location
  • Division
  • Business Sort descending
  • Functional Area
  • Date Posted
Job Title Site Location Division Business Sort descending Functional Area Date Posted
Treasury Manager Moscow (City) Russian Fed. Finance CTS Audit & Finance Jun 20, 2024
Analyst - SFE Products Hyderabad (Office) India Operations CTS Marketing May 20, 2024
Revenue Accounting Manager Shanghai (Shanghai) China Finance CTS Audit & Finance Jul 17, 2024
Project Controller INSURGENTES Mexico Operations Innovative Medicines Technical Operations Aug 13, 2024
Trial Vendor Senior Manager Hyderabad (Office) India Development Innovative Medicines Research & Development Sep 03, 2024
Project Manager Hyderabad (Office) India Operations Innovative Medicines Technical Operations Aug 13, 2024
Solution & Service Design Manager London (The Westworks) United Kingdom International Innovative Medicines Market Access Aug 15, 2024
QC Specialist I - Analytical Tuas South Avenue Singapore Operations Innovative Medicines Quality Sep 03, 2024
QC Specialist II - Analytical Tuas South Avenue Singapore Operations Innovative Medicines Quality Sep 03, 2024
QualityTeamLeader,QA Ops-Mfg Mgt(QA USP) Tuas South Avenue Singapore Operations Innovative Medicines Quality Sep 03, 2024
Engineering Lead, RLT CN Jiaxing (Zhejiang Province) China Operations Innovative Medicines Technical Operations Aug 19, 2024
Associate Analyst - Master Data Management Hyderabad (Office) India Operations Innovative Medicines Technical Operations Aug 19, 2024
Associate Analyst - Master Data Management Hyderabad (Office) India Operations Innovative Medicines Technical Operations Aug 19, 2024
Associate Analyst-Master Data Management Hyderabad (Office) India Operations Innovative Medicines Technical Operations Aug 19, 2024
Senior Cluster Procurement Manager for Slovenia Ljubljana Slovenia Operations Innovative Medicines Procurement Aug 19, 2024
Utilities Maintenance & Reliability Engineer - Site Amiria Egypt Operations Innovative Medicines Technical Operations Aug 19, 2024
Director HSPD Asset Lead and Expert London (The Westworks) Switzerland International Innovative Medicines Marketing Sep 03, 2024
Project Engineer (Design Phase)_RLT Sasayama Sasayama Japan Operations Innovative Medicines Technical Operations Sep 03, 2024
Key Account Manager, Haematology - South West Field Force (England / Wales) United Kingdom International Innovative Medicines Sales Aug 21, 2024
Director, Process Effectiveness & Reporting East Hanover USA US Innovative Medicines Marketing Sep 03, 2024
Site Engineering Head / Directeur Ingénierie et Maintenance (m/f/d) Huningue France Operations Innovative Medicines Technical Operations Sep 03, 2024
Administrative Expert / Professional RDQ Hyderabad (Office) India Development Innovative Medicines Facilities & Administration Aug 22, 2024
(Sr.) Sales Executive-Solid Tumor Hong Kong Hong Kong Special Administrative Region, China International Innovative Medicines Sales Aug 22, 2024
Ethics, Risk & Compliance Manager Selangor Malaysia Ethics Risk & Compliance Innovative Medicines Legal & Intellectual Property & Compl. Aug 22, 2024
Director Biostatistics London (The Westworks) United Kingdom Development Innovative Medicines Research & Development Aug 22, 2024
Business Planning and Analysis Manager, Novartis Technical Operations INSURGENTES Mexico Finance Innovative Medicines Audit & Finance Aug 22, 2024
Senior China Program Head Beijing (Beijing) China Development Innovative Medicines Research & Development Aug 22, 2024
Associate Clinical Development Medical Director Shanghai (Shanghai) China Development Innovative Medicines Research & Development Aug 22, 2024
Tactical planner İstanbul Kurtköy Turkey Operations Innovative Medicines Technical Operations Aug 23, 2024
Associate Manager - Quality Operations Hyderabad (Office) India Operations Innovative Medicines Quality Sep 03, 2024
P&O Business Partner Development & Biomedical Research Japan Head Office (Japan) (Pharmaceuticals) Japan People & Organization Innovative Medicines Human Resources Sep 03, 2024
Site Engineering Head Millburn USA Operations Innovative Medicines Technical Operations Aug 23, 2024
Responsabil produse & Expert în validare Targu Mures Romania Operations Innovative Medicines Technical Operations Sep 03, 2024
RA CMC Senior Manager Hyderabad (Office) India Development Innovative Medicines Research & Development Sep 03, 2024
Key Account Manager , Haematology - Yorkshire, East Midlands, Northamptonshire. Field Force (England / Wales) United Kingdom International Innovative Medicines Sales Sep 03, 2024
Clinical Development Functional Head London (The Westworks) United Kingdom Development Innovative Medicines Research & Development Sep 03, 2024
Specialist - Quality Operations Hyderabad (Office) India Operations Innovative Medicines Quality Sep 03, 2024
RA CMC Associate Manager-II Hyderabad (Office) India Development Innovative Medicines Research & Development Sep 03, 2024
Specialist – Quality Operations Hyderabad (Office) India Operations Innovative Medicines Quality Sep 03, 2024
Specialist – QOP Hyderabad (Office) India Operations Innovative Medicines Quality Sep 03, 2024
ASCVD Brand Manager Seoul South Korea International Innovative Medicines Marketing Sep 03, 2024
Quality Control Team Coordinator İstanbul Kurtköy Turkey Operations Innovative Medicines Quality Sep 03, 2024
BPA & R2R Analyst Amsterdam Netherlands Finance Innovative Medicines Audit & Finance Sep 04, 2024
Sr. Medical Science Liaison, ASCVD Seoul South Korea International Innovative Medicines Research & Development Sep 05, 2024
Senior Manager, Marketing- Cardiovascular Makati City Philippines International Innovative Medicines Marketing Sep 05, 2024
QC Specialist I - Raw Materials Tuas South Avenue Singapore Operations Innovative Medicines Quality Sep 05, 2024
Process Unit Maintenance Engineer - Site Amiria Egypt Operations Innovative Medicines Technical Operations Sep 05, 2024
Manufacturing Systems Expert Selangor Malaysia Operations Innovative Medicines Technical Operations Sep 05, 2024
Senior MR Haikou (Hainan Province) China International Innovative Medicines Sales Sep 05, 2024
Innovation Strategy Associate Director East Hanover USA Development Innovative Medicines Research & Development Sep 05, 2024

Pagination

  • ‹ Previous page
  • 1
  • …
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • …
  • 42
  • › Next page

Novartis United States

Navigate Novartis
  • Patients & caregivers
  • Healthcare professionals
  • ESG
  • News
  • Careers
Media center
  • News archive
  • Statements
  • Stories
Our portfolio
  • Novartis clinical pipeline
  • Novartis product portfolio
Other Novartis US websites
  • Oncology HCP resources
  • Medical information
  • Global site
Footer Bottom
© 2024 Novartis Pharmaceuticals Corporation
  • Terms of use
  • Privacy policy
  • Consumer health privacy policy
  • Contacts
  • Site map
  • Web accessibility
Novartis Site Directory
This site is intended for US residents only